Jefferies Group LLC Clovis Oncology, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $110,025 - $516,946	-174,644 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $222,319 - $488,169	155,468 Added 810.74%	174,644 $80,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $218,224 - $384,722	-80,824 Reduced 80.82%	19,176 $19,000
Q3 2021 Sep 21, 2023	BUY	$4.06 - $5.8 $404,270 - $577,529	99,574 Added 23374.18%	100,000 $446,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $405,999 - $580,000	100,000 New	100,000 $446,000
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $2,049 - $4,404	-426 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$4.13 - $6.41 $1,759 - $2,730	426 New	426 $2,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $32,651 - $50,677	-7,906 Reduced 94.89%	426 $2,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $7,798 - $12,490	1,618 Added 24.1%	8,332 $49,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $36,029 - $61,357	-6,332 Reduced 48.54%	6,714 $45,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $23,328 - $68,068	-6,188 Reduced 32.17%	13,046 $83,000
Q4 2019 Feb 13, 2020	SELL	$3.0 - $16.43 $535,119 - $2.93 Million	-178,373 Reduced 90.27%	19,234 $201,000
Q3 2019 Nov 13, 2019	BUY	$3.93 - $15.35 $688,001 - $2.69 Million	175,064 Added 776.58%	197,607 $777,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $83,815 - $167,958	6,543 Added 40.89%	22,543 $335,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $466,683 - $800,179	-26,426 Reduced 62.29%	16,000 $397,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $25,202 - $70,795	-2,167 Reduced 4.86%	42,426 $762,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $387,684 - $653,136	13,200 Added 42.05%	44,593 $1.31 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $1.32 Million - $1.96 Million	31,393 New	31,393 $1.43 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $147,202 - $198,893	-2,937 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $1.27 Million - $1.87 Million	-22,063 Reduced 88.25%	2,937 $200,000
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.68 Million - $2.12 Million	25,000	25,000 $2.06 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account